Please login to the form below

Not currently logged in

Verona names David Ebsworth as non-executive chairman

He joins from Vifor Pharma
Verona names David Ebsworth as non-executive chairman

Verona Pharma has appointed Dr David Ebsworth as its non-executive chairman of the board of directors.

Ebsworth's role will be effective from December 1 when he will take over from Prof Clive Page, who has held the position since founding the company in 2006.

Ebsworth (pictured) is an experienced pharma executive who has worked at board and senior management level at a number of international companies. He most recently served as CEO at Vifor Pharma and was also named CEO of Galenica in 2011, continuing to be an adviser for both firms.

His career in the pharma industry spans over 35 years, including a 19-year stint at Bayer where he worked up through the company from product manager to general manager of the global pharma division.

Commenting on his appointment, Ebsworth said: “I am looking forward to working closely with Verona Pharma's board and management to guide the company towards success. I shall use my background and experience in both international pharma and biotech to support this innovative company within the hugely rewarding respiratory space.”

Dr Jan-Anders Karlsson, CEO of Verona Pharma, said: “We thank Clive for all his achievements as we welcome David to the board. David' significant expertise in the pharma industry strongly supports Verona Pharma's focus on high value commercial opportunities and future growth.”

24th November 2014

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Redline Strategic

We are a healthcare consultancy, specialising in people and experiences. Using innovative research methods to capture the thoughts of real...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...